Capital CS Group’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-17,525
| Closed | -$410K | – | 86 |
|
|
2024
Q3 | $410K | Hold |
17,525
| – | – | 0.48% | 36 |
|
|
2024
Q2 | $312K | Hold |
17,525
| – | – | 0.35% | 46 |
|
|
2024
Q1 | $267K | Hold |
17,525
| – | – | 0.25% | 60 |
|
|
2023
Q4 | $299K | Hold |
17,525
| – | – | 0.33% | 38 |
|
|
2023
Q3 | $147K | Hold |
17,525
| – | – | 0.17% | 53 |
|
|
2023
Q2 | $435K | Hold |
17,525
| – | – | 0.43% | 27 |
|
|
2023
Q1 | $264K | Hold |
17,525
| – | – | 0.25% | 44 |
|
|
2022
Q4 | $207K | Hold |
17,525
| – | – | 0.23% | 39 |
|
|
2022
Q3 | $104K | Hold |
17,525
| – | – | 0.11% | 44 |
|
|
2022
Q2 | $74K | Hold |
17,525
| – | – | 0.08% | 38 |
|
|
2022
Q1 | $167K | Sell |
17,525
-4,700
| -21% | -$44.8K | 0.15% | 49 |
|
|
2021
Q4 | $423K | Buy |
22,225
+4,700
| +27% | +$89.5K | 0.33% | 48 |
|
|
2021
Q3 | $591K | Buy |
+17,525
| New | +$591K | 0.55% | 35 |
|